Movement Alert|Moderna, Inc. Falls 4.38% in Regular Trading, Trading at $153.105

Market Focus
Sep 19

On September 19, Moderna, Inc. fell 4.38% in regular trading, trading at $153.105 USD/share, with Turnover of $12.73 billion.

Within the Biotechnology sector where Moderna, Inc. belongs, individual stock performance was mixed. Among individual stocks, Amgen up 1.1%, Halozyme Therapeutics up 1.94%, Gilead Sciences down 0.66%, AbbVie up 0.16%, Xenon Pharmaceuticals down 31.6%.

Moderna, Inc. is a biotechnology company that discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases. Its portfolio spans respiratory vaccines, latent vaccines, public health vaccines, cancer vaccines including personalized cancer and checkpoint vaccines, as well as intratumoral immuno-oncology products. The company maintains strategic collaborations with AstraZeneca, Merck, Vertex Pharmaceuticals, and other partners.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10